Pharmacokinetics of Intravail® A3 (n-dodecyl-beta-D-maltoside), a Mucosal Absorption Enabler, After Intranasal Administration of NRL-1 in Patients with Epilepsy
Publication/Presentation Date
4-2020
Volume
94
Issue
15
First Page
1918
Last Page
1918
Published In/Presented At
Disciplines
Medicine and Health Sciences
Department(s)
Department of Medicine
Document Type
Article
COinS